Clinical Trials in Denver

Showing 981-1000 of 15,604 trials

PPROM Registry (Preterm Premature Rupture of Membranes)

NCT02997345

Preterm Premature Rupture of Membranes (PPROM) before 37 weeks of pregnancy is responsible for 40% of preterm births in the United States. The PPROM Registry aims to identify possible causes of PPROM, evaluate trends in expectant management, measure maternal and fetal care, and to review short term and long term outcomes of affected pregnancies and births.

Fetal Membranes, Premature RupturePreterm Premature Rupture of the MembranesOligohydramnios+1 more

American Alliance for pProm Support3,000 participantsStarted Jul 2013

Denver, Colorado, United States

RECRUITING5.0 miles

This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate or Switch Any Systemic Treatment

NCT07290803

The objectives of this prospective non-interventional study are to characterize the existing unmet needs across the spectrum of atopic dermatitis (AD), enhance the understanding of the patient journey, and evaluate the safety and clinical outcomes of systemic AD treatments in a real-world setting. Additionally, patient-specific factors (such as age, skin color, AD flare triggers, previous treatment responses, comorbid conditions, and the extent and site of lesions) will be assessed to better characterize the impact on the treatment journey across a broad age range and diverse geographic regions. The study will be conducted across 10 countries in 4 different geographical regions, with a follow-up period of 5 years.

Atopic Dermatitis

Sanofi1,000 participantsStarted Nov 2025

Birmingham, Alabama, United States • Montgomery, Alabama, United States • Gilbert, Arizona, United States +32 more locations

PPROM Registry (Preterm Premature Rupture of Membranes)

This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate or Switch Any Systemic Treatment

Find Trials by Condition in Denver

A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease

I-SPY COVID-19 TRIAL: An Adaptive Platform Trial for Critically Ill Patients

Multicenter Clinical Trial of a Phakic Implantable Collamer® Lens (ICL)

Mucopolysaccharidosis VII Disease Monitoring Program

Study of Ibrutinib and Rituximab in Treatment Naïve Follicular Lymphoma

Objective Assessment of Intraocular Lens Tilt and Decentration

A Comparison of Fractional Flow Reserve-Guided Percutaneous Coronary Intervention and Coronary Artery Bypass Graft Surgery in Patients With Multivessel Coronary Artery Disease

A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation

A Long-term Study for Participants Previously Treated With Ciltacabtagene Autoleucel

A Long-term Safety and Efficacy Study of Danicopan as an Add-on Therapy to Complement Component 5 Inhibitor (C5i) in Participants With PNH

(Neo)Adjuvant IDE196 (Darovasertib) in Patients With Localized Ocular Melanoma

A Non-Interventional Study Observing Short-Term Progression in Geographic Atrophy (GA)

Donidalorsen Treatment in Children With Hereditary Angioedema

Safety, Tolerability and Efficacy of QRX003 Lotion in Subjects With Netherton Syndrome

rHSC-DIPGVax Plus Checkpoint Blockade for the Treatment of Newly Diagnosed DIPG and DMG

Study of Pembrolizumab in Locally Advanced Esophageal Adenocarcinoma

Safety of RSV Preventive Monoclonal Antibody

Tolerability Study of Trichostatin A In Subjects With Relapsed or Refractory Hematologic Malignancies